Birmingham Biotech, a global manufacturer and supplier of innovative medical diagnostic equipment and devices, has become the seventh Birmingham-born company to enter the University of Birmingham Enterprise’s MedTech incubator, Unit 9. With operations spanning Asia, Latin America, Africa, and the UK, Birmingham Biotech is now part of the thriving ecosystem at Birmingham Research Park, which has been nurturing high-growth companies since 1986.

Unit 9, established in 2022, is designed to support emerging companies within Birmingham’s vibrant medical technology scene. It complements the city's existing infrastructure for translational work, providing short-term incubation and a comprehensive business support programme, including an equipment-sharing agreement with the University of Birmingham.

Photo Credit: University of Birmingham

Angie Reynolds, Chief Operating Officer at University of Birmingham Enterprise, highlighted the significance of the addition:

The incubator is a collaborative effort between the University of Birmingham Enterprise, the GBSLEP Growth Hub, and the West Midlands Combined Authority, aiming to foster innovation, creativity, and growth in the city. Located at Birmingham Research Park, Unit 9 offers a range of landing spaces, including the BioHub Birmingham, which provides facilities for cell culture and microbiology work to its tenants.

Michael Hsu, Managing Director of Birmingham Biotech, expressed enthusiasm about the new space:

The Midlands health and life sciences sector is home to the UK’s largest cluster of medical technology businesses, excelling in diagnostics, devices, digital, and data. The region also boasts world-leading research institutes and the clinical infrastructure necessary for large-scale trials, making it an ideal location for Birmingham Biotech's continued growth and innovation.